Terms: = Lung cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Prognosis
277 results:
1. Transitioning to a Personalized Approach in Molecularly Subtyped Small-Cell lung cancer (SCLC).
Grenda A; Krawczyk P; Obara A; Gajek Ł; Łomża-Łaba A; Milanowski J
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673793
[TBL] [Abstract] [Full Text] [Related]
2. Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1.
Li J; Ma X; Xu F; Yan Y; Chen W
Pharm Biol; 2024 Dec; 62(1):314-325. PubMed ID: 38571483
[TBL] [Abstract] [Full Text] [Related]
3. Suppression of NSCLC progression via the co-administration of Danusertib, an AURK inhibitor, and KRIBB11, an HSF1 inhibitor.
Zhang X; Lei Y; Chen X; He J; Liu Z; Zhu W; Xu Y; Jin X
Biochem Pharmacol; 2024 May; 223():116155. PubMed ID: 38521474
[TBL] [Abstract] [Full Text] [Related]
4. KIF20B Correlates with LUAD Progression and Is an Independent Risk Factor.
Yang J; Xu L; Han X
Crit Rev Eukaryot Gene Expr; 2024; 34(3):49-59. PubMed ID: 38305288
[TBL] [Abstract] [Full Text] [Related]
5. Unveiling the potential effects of resveratrol in lung cancer treatment: Mechanisms and nanoparticle-based drug delivery strategies.
Najafiyan B; Bokaii Hosseini Z; Esmaelian S; Firuzpour F; Rahimipour Anaraki S; Kalantari L; Hheidari A; Mesgari H; Nabi-Afjadi M
Biomed Pharmacother; 2024 Mar; 172():116207. PubMed ID: 38295754
[TBL] [Abstract] [Full Text] [Related]
6. CEBPA facilitates LOXL2 and LOXL3 transcription to promote bcl-2 stability and thus enhances the growth and metastasis of lung carcinoma cells in vitro.
Fan L; Jiang W; Chen C; Gao H; Shi J; Wang D
Exp Cell Res; 2024 Feb; 435(2):113937. PubMed ID: 38242344
[TBL] [Abstract] [Full Text] [Related]
7. Protein tyrosine phosphatase PTPRO represses lung adenocarcinoma progression by inducing mitochondria-dependent apoptosis and restraining tumor metastasis.
Dai Y; Shi S; Liu H; Zhou H; Ding W; Liu C; Jin L; Xie W; Kong H; Zhang Q
Cell Death Dis; 2024 Jan; 15(1):11. PubMed ID: 38182570
[TBL] [Abstract] [Full Text] [Related]
8. Identification of SRSF10 as a promising prognostic biomarker with functional significance among SRSFs for glioma.
An W; Yang Q; Xi Y; Pan H; Huang H; Chen Q; Wang Y; Hua D; Shi C; Wang Q; Sun C; Luo W; Li X; Yu S; Zhou X
Life Sci; 2024 Feb; 338():122392. PubMed ID: 38160788
[TBL] [Abstract] [Full Text] [Related]
9. The role of α7-nAChR-mediated PI3K/AKT pathway in lung cancer induced by nicotine.
He Z; Xu Y; Rao Z; Zhang Z; Zhou J; Zhou T; Wang H
Sci Total Environ; 2024 Feb; 912():169604. PubMed ID: 38157907
[TBL] [Abstract] [Full Text] [Related]
10. Light dose effect of photodynamic therapy on growth inhibition and apoptosis induction in non-small cell lung cancer: A study in nude mouse model.
Sun W; Ma X; Wang Y; Yang G; Liao J; Cheng Y; Wang G
Photodiagnosis Photodyn Ther; 2023 Dec; 44():103865. PubMed ID: 37949389
[TBL] [Abstract] [Full Text] [Related]
11. [Clinical pathological characteristics analysis of ocular adnexal follicular lymphoma].
Li J; Wang YC; Lin JY
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):930-936. PubMed ID: 37936361
[No Abstract] [Full Text] [Related]
12. POU2F3-Expressing Small Cell lung Carcinoma and Large Cell Neuroendocrine Carcinoma Show Morphologic and Phenotypic Overlap.
Jimbo N; Ohbayashi C; Takeda M; Fujii T; Mitsui S; Tsukamoto R; Tanaka Y; Itoh T; Maniwa Y
Am J Surg Pathol; 2024 Jan; 48(1):4-15. PubMed ID: 37904277
[TBL] [Abstract] [Full Text] [Related]
13. ORM1 promotes tumor progression of kidney renal clear cell carcinoma (KIRC) through CALR-mediated apoptosis.
Yu G; Gao J; Hu W; Hu D; Wang W; Yang S; Gao J
Sci Rep; 2023 Sep; 13(1):15687. PubMed ID: 37735575
[TBL] [Abstract] [Full Text] [Related]
14. Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC.
Simiene J; Dabkeviciene D; Stanciute D; Prokarenkaite R; Jablonskiene V; Askinis R; Normantaite K; Cicenas S; Suziedelis K
BMC Cancer; 2023 Sep; 23(1):857. PubMed ID: 37697308
[TBL] [Abstract] [Full Text] [Related]
15. JSI-124 inhibits cell proliferation and tumor growth by inducing autophagy and apoptosis in murine malignant mesothelioma.
Zhang C; Sun Q; Zhao J; Jiang N; Hao Y; Luo J; Karim S; Wu L; de Perrot M; Peng C; Zhao X
Mol Carcinog; 2023 Dec; 62(12):1888-1901. PubMed ID: 37642305
[TBL] [Abstract] [Full Text] [Related]
16. Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.
Tsakonas G; Tadigotla V; Chakrabortty SK; Stragliotto G; Chan D; Lewensohn R; Yu W; Skog JK; Hydbring P; Ekman S
Lung Cancer; 2023 Aug; 182():107292. PubMed ID: 37423059
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic roles of hematological indicators for the efficacy and prognosis of immune checkpoint inhibitors in patients with advanced tumors: a retrospective cohort study.
Zheng F; Meng Q; Zhang L; Chen J; Zhao L; Zhou Z; Liu Y
World J Surg Oncol; 2023 Jul; 21(1):198. PubMed ID: 37420219
[TBL] [Abstract] [Full Text] [Related]
18. Optimizing treatment of brain metastases in an era of novel systemic treatments: a single center consecutive series.
van Schie P; Rijksen BLT; Bot M; Wiersma T; Merckel LG; Brandsma D; Compter A; de Witt Hamer PC; Post R; Borst GR
J Neurooncol; 2023 Jun; 163(2):345-354. PubMed ID: 37266846
[TBL] [Abstract] [Full Text] [Related]
19. Phosphorylation of bcl-2 by JNK confers gemcitabine resistance in lung cancer cells by reducing autophagy-mediated cell death.
Chiu CH; Ramesh S; Liao PH; Kuo WW; Chen MC; Kuo CH; Li CC; Wang TF; Lin YM; Lin YJ; Huang CY
Environ Toxicol; 2023 Sep; 38(9):2121-2131. PubMed ID: 37219008
[TBL] [Abstract] [Full Text] [Related]
20. Hsa_circ_0070661 inhibits cancer progression through miR-556-5p/TEK axis in lung adenocarcinoma.
Chen Y; Wu Y
Cancer Biomark; 2023; 37(1):53-66. PubMed ID: 37005879
[TBL] [Abstract] [Full Text] [Related]
[Next]
